SHANGHAI, Sept. 30, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its senior management will be participating in the following upcoming conferences in October 2011:

Mr. Kevin Chen, Chief Operating Officer of ShangPharma; Mr. William Dai, Chief Financial Officer; and Ms. Lan Xie, Vice President of Finance and Investor Relations, will be presenting at the following conference in Macau:

    --  Citi Greater China Investor ConferenceOctober 19-20, 2011Macau, PRC

Mr. William Dai, Chief Financial Officer of ShangPharma, will be presenting at the following conferences in Beijing:

    --  Goldman Sachs China Investment Frontier ConferenceOctober 27-28,
        2011Beijing, PRC


    --  Bank of America Merrill Lynch New China ConferenceOctober 31-November 4,
        2011Beijing, PRC

Presentation materials will be available under the Webcasts & Presentations section of the Company's investor relations website at http://ir.shangpharma.com. Investors interested in meeting with ShangPharma during any of the above conferences should contact the relevant institutional sales representatives.

About ShangPharma Corporation

ShangPharma Corporation is a leading China-based contract research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit www.shangpharma.com.



    For further information, please contact:

    ShangPharma Corporation

    In Shanghai, China
    Ms. Lan Xie
    VP of Finance and Investor Relations
    Email: IR@shangpharma.com

    Christensen

    In New York:
    Kimberly Minarovich
    Tel: +1 917-533-3268
    Email: kminarovich@christensenir.com

    In Hong Kong:
    Tip Fleming
    Tel: +852-9212-0684
    Email: tfleming@christensenir.com
    ---------------------------------

SOURCE ShangPharma Corporation